3 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Molecular docking studies demonstrated that these bioactive compounds exhibit favorable binding affinities toward COX-2, XO, α-glucosidase, and Keap1, supporting their potential anti-inflammatory, antioxidant, antidiabetic, and anti-gout activities.
Findings identify glycopentamide B as the most promising CDK4-binding candidate among the investigated compounds and support its further evaluation as a potential anticancer lead.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
